US Stock MarketDetailed Quotes

TARA Protara Therapeutics

Watchlist

2.400
+0.020+0.84%

Close Jul 16 16:00 ET

49.42MMarket Cap-641P/E (TTM)

Protara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

21.77%11.85M

16.16%43.61M

10.50%11.04M

34.19%10.7M

39.46%12.14M

-10.50%9.73M

-20.94%37.55M

-2.87%9.99M

-26.37%7.97M

-31.95%8.71M

Selling and administrative expenses

-10.59%4.1M

-10.19%18.62M

-6.86%4.66M

-0.58%4.48M

-12.95%4.89M

-18.13%4.59M

-21.45%20.74M

-19.55%5M

-33.09%4.51M

-18.60%5.62M

-General and administrative expense

-10.59%4.1M

-10.19%18.62M

-6.86%4.66M

-0.58%4.48M

-12.95%4.89M

-18.13%4.59M

-21.45%20.74M

-19.55%5M

-33.09%4.51M

-18.60%5.62M

Research and development costs

50.65%7.75M

48.67%24.99M

27.90%6.38M

79.40%6.22M

134.99%7.25M

-2.39%5.14M

-20.30%16.81M

22.64%4.99M

-15.32%3.47M

-47.61%3.08M

Operating profit

-21.77%-11.85M

-16.16%-43.61M

-10.50%-11.04M

-34.19%-10.7M

-39.46%-12.14M

10.50%-9.73M

20.94%-37.55M

2.87%-9.99M

26.37%-7.97M

31.95%-8.71M

Net non-operating interest income expense

8.73%747K

191.03%3.18M

55.05%814K

196.11%838K

407.23%842K

477.31%687K

361.18%1.09M

789.83%525K

433.96%283K

1,560.00%166K

Non-operating interest income

8.73%747K

42.65%3.18M

28.80%814K

50.45%838K

64.45%842K

29.87%687K

12.97%2.23M

22.48%632K

1.83%557K

-0.19%512K

Non-operating interest expense

----

-34.54%1.14M

-76.59%107K

-44.53%274K

-31.21%346K

Other net income (expense)

100.04%12K

-29.5M

Gain on sale of security

--9K

-29.41%12K

--6K

--2K

--4K

----

--17K

----

Special income (charges)

----

--0

----

---29.52M

----

-Less:Impairment of capital assets

----

--0

----

--29.52M

----

Income before tax

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

33.20%-8.54M

Income tax

Net income

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

33.20%-8.54M

Net income continuous Operations

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

33.20%-8.54M

Minority interest income

Net income attributable to the parent company

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

33.20%-8.54M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

33.20%-8.54M

Basic earnings per share

-21.25%-0.97

39.08%-3.57

73.99%-0.9

-27.94%-0.87

-31.58%-1

16.67%-0.8

-39.19%-5.86

-280.22%-3.46

29.17%-0.68

33.33%-0.76

Diluted earnings per share

-21.25%-0.97

39.08%-3.57

73.99%-0.9

-27.94%-0.87

-31.58%-1

16.67%-0.8

-39.19%-5.86

-280.22%-3.46

29.17%-0.68

33.33%-0.76

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	21.77%11.85M	16.16%43.61M	10.50%11.04M	34.19%10.7M	39.46%12.14M	-10.50%9.73M	-20.94%37.55M	-2.87%9.99M	-26.37%7.97M	-31.95%8.71M
Selling and administrative expenses	-10.59%4.1M	-10.19%18.62M	-6.86%4.66M	-0.58%4.48M	-12.95%4.89M	-18.13%4.59M	-21.45%20.74M	-19.55%5M	-33.09%4.51M	-18.60%5.62M
-General and administrative expense	-10.59%4.1M	-10.19%18.62M	-6.86%4.66M	-0.58%4.48M	-12.95%4.89M	-18.13%4.59M	-21.45%20.74M	-19.55%5M	-33.09%4.51M	-18.60%5.62M
Research and development costs	50.65%7.75M	48.67%24.99M	27.90%6.38M	79.40%6.22M	134.99%7.25M	-2.39%5.14M	-20.30%16.81M	22.64%4.99M	-15.32%3.47M	-47.61%3.08M
Operating profit	-21.77%-11.85M	-16.16%-43.61M	-10.50%-11.04M	-34.19%-10.7M	-39.46%-12.14M	10.50%-9.73M	20.94%-37.55M	2.87%-9.99M	26.37%-7.97M	31.95%-8.71M
Net non-operating interest income expense	8.73%747K	191.03%3.18M	55.05%814K	196.11%838K	407.23%842K	477.31%687K	361.18%1.09M	789.83%525K	433.96%283K	1,560.00%166K
Non-operating interest income	8.73%747K	42.65%3.18M	28.80%814K	50.45%838K	64.45%842K	29.87%687K	12.97%2.23M	22.48%632K	1.83%557K	-0.19%512K
Non-operating interest expense	----	----	----	----	----	----	-34.54%1.14M	-76.59%107K	-44.53%274K	-31.21%346K
Other net income (expense)	9K	100.04%12K	6K	2K	4K		-29.5M
Gain on sale of security	--9K	-29.41%12K	--6K	--2K	--4K	----	--17K	----	----	----
Special income (charges)	----	--0	----	----	----	----	---29.52M	----	----	----
-Less:Impairment of capital assets	----	--0	----	----	----	----	--29.52M	----	----	----
Income before tax	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M	33.20%-8.54M
Income tax
Net income	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M	33.20%-8.54M
Net income continuous Operations	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M	33.20%-8.54M
Minority interest income
Net income attributable to the parent company	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M	33.20%-8.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M	33.20%-8.54M
Basic earnings per share	-21.25%-0.97	39.08%-3.57	73.99%-0.9	-27.94%-0.87	-31.58%-1	16.67%-0.8	-39.19%-5.86	-280.22%-3.46	29.17%-0.68	33.33%-0.76
Diluted earnings per share	-21.25%-0.97	39.08%-3.57	73.99%-0.9	-27.94%-0.87	-31.58%-1	16.67%-0.8	-39.19%-5.86	-280.22%-3.46	29.17%-0.68	33.33%-0.76
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall